Effects of Victoza (Liraglutide) Versus Lyxumia (Lixisenatide) on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2018
Price : $35 *
At a glance
- Drugs Liraglutide (Primary) ; Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Jul 2018 Status changed from active, no longer recruiting to discontinued.
- 14 May 2018 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 14 May 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Jul 2018.